(Q86611573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

cardiovascular abnormality

28 February 2020

main subject

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Christophe Tribouilloy

10

object named as

Christophe Tribouilloy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Julien Maizel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Isabelle Six

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sebastien Dupont

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Edouard Secq

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Benedicte Dehedin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Fellype C Barreto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Joyce Benchitrit

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sabrina Poirot

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Michel Slama

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Gabriel Choukroun

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jean C Mazière

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ziad A Massy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

17 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

491-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23594676%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2013.110

28 February 2020

exact match

0 references

cites work

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Phosphorus levels are associated with subclinical atherosclerosis in the general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Vascular calcification: in vitro evidence for the role of inorganic phosphate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Phosphate regulation of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Dietary phosphorus acutely impairs endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Direct effects of phosphate on vascular cell function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Pleiotropic effects of the non-calcium phosphate binder sevelamer.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

FGF23 induces left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Cardiorenal syndrome: the emerging role of protein-bound uremic toxins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

αKlotho: FGF23 coreceptor and FGF23-regulating hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Effects of phosphate on vascular function under normal conditions and influence of the uraemic state

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Left ventricular alterations and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Novel markers of left ventricular hypertrophy in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Development and progression of uremic changes in the mouse with surgically induced renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021

Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.110

7 January 2021